Biocom California’s top priority is the safety of our members and the well-being of our employees. After careful consideration, Biocom California has decided to transform our 2021 Global Life Science Partnering Conference to a fully virtual event. We know that many lives are being impacted and disrupted by COVID-19 and we are grateful to be able to continue offering our members valuable content in a safe manner.
Close
Global Head Mergers & Acquisitions and Business Development & Licensing, Novartis
Nigel Sheail is Global Head of Mergers & Acquisitions and Business Development & Licensing since September 1st, 2017 and joined Novartis in 2015 as Head of Business Development & Licensing. He is a member of the Financial Leadership Team and Executive Deal Committee.
Before joining Novartis, Nigel Sheail was Global Head of Business Development and Licensing at Bayer Healthcare AG. Prior to that Nigel Sheail was Global Head of Licensing and Head of Corporate M&A at F.Hoffmann-La Roche Ltd..
Nigel Sheail received a B.Sc (Hons. Molecular Biology) from Edinburgh University in 1987. In 1989, he became an Associate Chartered Accountant while at Ernst and Young.